Australia's November Pharmaceutical Benefits Advisory Committe (PBAC) meeting will consider listing Idelalisib and Ibrutinib for CLL patients.
Idelalisib is on the agenda for a major submission to list it for the treatment of CLL in patients with progressive disease despite previous treatment.
Ibrutinib's second listing attempt is for relapsed or refractory CLL and SLL. No doubt the sponsor will address what it can of the points raised in the previous PBAC meeting, but actual patient experiences - possibly from you! bear considerable weight.
The agenda can be found here, as can the link to the Consumer Comments Submission form:
The deadline for these consumer comments is next Wednesday, 7th October 2015
All CLL patients are encouraged to respond, with the PBAC particularly interested in hearing from CLL patients that have had experience of Ibrutinib or Idelalisib. So particularly if you've had treatment with either of these, please provide the PBAC with your experiences (and compare them with your earlier treatments!!)
Filling this in is very easy; it's a well guided process. Please concentrate on the advantages of the new drugs compared to your earlier treatments, e.g. they'll work when you have bad deletions and when your response to further chemo treatments is diminished from previous treatments, they have less/less severe side effects, you feel more well and are actually able to do more if that's been your experience, etc.
Thanks on the behalf of all Australians with CLL looking to gain affordable access to non-chemo treatments, particularly when they are running out of options.
Neil
Written by
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Andy, thanks for your question. There's no restriction on who can provide submissions. Given the limited number of patients in Australia that have actually been treated with these new drugs, I'm sure the PBAC would appreciate submissions from anyone that can provide a patient's perspective on how Ibrutinib and Idelalisib perform compared to other alternatives.
Hi Aussie Neil, i am not Australian but my son lives there. I have been on Ibrutinib for 9 months havong relapsed again. I am happy to write a letter in support of the drug but cant work out how to send from your link! Sorry.
Plus there's explanatory help adjacent to the fields you fill in, guiding you as to what they are after in that field.
To complete the online form, just go through the process for Ibrutinib or Idelalisib (or both). Here are some tips for some of the fields:
Date of the meeting: November 2015
Declarations section: Something along the lines of : Have CLL/SLL, have CLL and have already been treated and am concerned at the shorter remission time likely with available treatments, refractory to existing treatment(s), carer for some with CLL/SLL, related to someone with CLL/SLL, concerned citizen or whatever you consider is appropriate
How did you learn about this consumer submission process
H e a l t h U n l o c k e d . c o m / C L L S u p p o r t
I just opened two tabs on my browser and copied the common content across to both submissions.
Hope that helps, but please don't hesitate to ask for any further clarification.
Does putting a minus '-' in front of your postal code work? Australian post codes are limited to just 4 numbers, but overseas respondents found the minus trick worked previously. If not, just use Canberra's post code: 2600, where Australia's Parliament House is located
I had the same proble brenda so ended up putting my sons postcode as he lives in australia. I then added a note explaining that it wouldnt accept my uk one and then imcluded it. To get around the problem put in 2454 and it will accept that.
I used the postal code that Neil gave me and it went through .Thank you anyway .I have had a problem posting for the last few days .Some of my posts don't get through .
The HU site has been having difficulties for the last few days, so we've all had problems accessing the site . It seems to be getting back to normal...
Separate forms - one for each drug? Any of us can certainly say that we have seen the benefit as members of a support group. There were a couple of categories that we would all fit in. Have you posted this on CLL Forum? Lots of people there using one or the other and / or following on line friends who are.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
. It seems to be getting back to normal...
Adding Venetoclax to Obinutuzumab Prolongs Progression-Free Survival in Previously Untreated CLL
New Review Article about Venetoclax
STEP ONE OF MY THIRD CLINICAL TRIAL huCAR-T19 IL-18
Road to a BMT... oops just got there (Day +101)
